Results 241 to 250 of about 27,616 (258)

Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer

Chest, 2017
Monica Khunger, Adrian V Hernandez, Peter J Mazzone   +2 more
exaly  

Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis

International Journal of Radiation Oncology Biology Physics, 2013
Suresh Senan, Kayoko Tsujino, Ramesh Rengan   +2 more
exaly  

Pneumonitis in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors

Journal of Thoracic Oncology, 2018
Karthik Suresh, Khinh Ranh Voong, Patrick Forde   +2 more
exaly  

Occupational hypersensitivity pneumonitis: an EAACI position paper

Allergy: European Journal of Allergy and Clinical Immunology, 2016
O Vandenplas
exaly  

Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2‐targeting Ab–drug conjugate, in monkeys

Cancer Science, 2020
Kazuyoshi Kumagai, Kazuhiko Mori
exaly  

Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies

ESMO Open, 2022
exaly  

Radiation Pneumonitis: Old Problem, New Tricks

Cancers, 2018
Varsha Jain, Abigail T Berman
exaly  

Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance

Science Translational Medicine, 2019
Elise M N Ferré, Timothy J Break, Peter Burbelo   +2 more
exaly  

Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer

Lung Cancer, 2018
Junghoon Kim, Jong Seok Lee, Yu Jung Kim
exaly  

Immune Checkpoint Inhibitor Therapy–related Pneumonitis: Patterns and Management

Radiographics, 2019
Kevin Kalisz, Kai Roman Laukamp, Amit Gupta   +2 more
exaly